Dont' let Sleep Apnea keep you from Huge Profits!
|
|
SIMH Sandomedics
is treating patients one night at a time!
More than 18 Million Americans suffer from Sleep Apnea and many are not receiving treatment!
Sleep apnea often goes undiagnosed. Doctors usually can't detect the condition during routine office visits. Also, no blood test can help diagnose the condition.
Most people who have sleep apnea don't know they have it because it only occurs during sleep. A family member or bed partner might be the first to notice signs of sleep apnea.
|
|
SIMH is a company with a strong plan, extant financing resources, and a big and rapidly growing end market. None of these three factors were in place a few months ago. That's a tremendous evolution without basically any change in price/share. Therein may we infer the value at present.
SIMH has Huge Breakout Potential!
L |
|
|
Why SIMH? - RECENT DEVELOPMENTS!
SIMH Secures $5M Revolving Credit Facility With TCA Global Credit Master Fund, LP To Fund Growth And Future Acquisitions
Jan. 13, 2014 (OTCQB: SIMH) A medical technology holding company that focuses on game-changing products, services and ideas, today announced that on January 9, 2014, it and all of its wholly owned subsidiaries closed a Senior Secured Revolving Credit Facility of up to $5M with TCA Global Credit Master Fund, LP ("TCA") to provide operating capital and fund acquisitions.
On the date of closing, $1M of the Revolving Credit Facility was funded. The Company intends to use the remainder of the facility ($4M) primarily to fund accretive acquisitions. Additional draws under the facility are available on an as-needed basis, based on a mutually approved formula of eligible receivables and assets, subject to continuing compliance with the terms of the revolving credit facility.
Keith Houlihan, President of Sanomedics International Holdings, Inc., said "The TCA funding and support is another significant step forward in our development and strategic growth plans. This facility and partnership with TCA will demonstrate our funding capabilities and strength in identifying targeted acquisitions and position to execute."
About TCA Global Credit Master Fund, LP
TCA Global Master Fund, TCA, is a short duration, absolute return fund specializing in senior secured lending and advisory services to small, mainly listed companies predominantly in the United States of America, Canada, Western Europe and Australia.
TCA's specialist business fills the underserved small-cap lending gap that exists in these leading markets . The TCA team has an unparalleled level of domestic and cross-border expertise, long-standing relationships and a history of comprehensive funding innovations.
This reflects in its history of successful, completed transaction and high level of repeat business. Additional information may be found at www.tcaglobalfund.com SIMH is a medical technology holding company that focuses on game changing products, services and ideas – a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization.
We plan to grow our existing business organically and through strategic acquisitions specifically relating to sleep disorder diagnosis treatments. Sanomedics seeks to acquire sleep therapy operating businesses and our strategy is to integrate a portfolio of world-class products and service providers in the growing Sleep Apnea market.
Our goal is to provide Sleep Apnea patients with a reliable and integrated “end-to-end” service platform.
As a pioneer in the trend toward preventive medicine, Sanomedic’s goal is to act as a bridge between the high-tech medical world and the home healthcare environment.
All Sanomedics professional and home healthcare products are designed to be easy to use while providing a high degree of health benefits and accurate results. |
|
|
SIMH - Back Over $1 And Beyond A Blue Sky Buck?
(OtcMarket Float: 1.1M )
SIMH is Bullish for Many Reasons Right Now and the market is loving the recently secured $5m line of revolving credit along side a very much anticipated note that Was Paid In Full.
It`s exactly what investors have been waiting for and if you check the dates you can see this is when the SIMH chart started to head Back into the Uptrend.
Quick Snip From The 8k (1/23/2014) and the $5M News before we take a closer look at SIMH The Company...
"The Note is now paid in full and the Company has no further obligation with respect to the Note."
|
|
|
Don't Sleep thru this Amazing Company and There Huge Growth potential!
SIMH is a company with a strong plan, extant financing resources, and a big and rapidly growing end market. None of these three factors were in place a few months ago. That's a tremendous evolution without basically any change in price/share.
What's more, the financing now in place will not allow for significant strategic moves to be made, but will also allow for some much-needed PR and pandering to the press.
That has the market very interested and if your looking for a great entry on low-key stock with a massive amount of upside way past a Buck, This is It!
|
|
|
|
(0)
(0)